Adage Capital Partners GP L.L.C. reduced its stake in shares of BrightSpring Health Services, Inc. (NASDAQ:BTSG - Free Report) by 60.3% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 383,377 shares of the company's stock after selling 581,153 shares during the period. Adage Capital Partners GP L.L.C. owned approximately 0.22% of BrightSpring Health Services worth $6,529,000 at the end of the most recent reporting period.
Several other hedge funds have also recently bought and sold shares of BTSG. Rhumbline Advisers grew its holdings in shares of BrightSpring Health Services by 1.5% during the fourth quarter. Rhumbline Advisers now owns 73,583 shares of the company's stock worth $1,253,000 after buying an additional 1,118 shares in the last quarter. MetLife Investment Management LLC boosted its holdings in BrightSpring Health Services by 4.9% in the 4th quarter. MetLife Investment Management LLC now owns 33,117 shares of the company's stock worth $564,000 after acquiring an additional 1,548 shares during the period. Legal & General Group Plc increased its position in shares of BrightSpring Health Services by 4.8% during the fourth quarter. Legal & General Group Plc now owns 64,631 shares of the company's stock worth $1,101,000 after acquiring an additional 2,945 shares during the last quarter. R Squared Ltd bought a new stake in shares of BrightSpring Health Services in the fourth quarter worth $74,000. Finally, Geode Capital Management LLC grew its position in shares of BrightSpring Health Services by 0.5% in the 4th quarter. Geode Capital Management LLC now owns 1,311,204 shares of the company's stock worth $22,335,000 after acquiring an additional 6,990 shares in the last quarter.
Wall Street Analyst Weigh In
Separately, UBS Group boosted their target price on shares of BrightSpring Health Services from $22.00 to $30.00 and gave the company a "buy" rating in a research note on Wednesday, January 29th. One research analyst has rated the stock with a hold rating and nine have issued a buy rating to the company's stock. Based on data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus target price of $21.67.
Read Our Latest Report on BrightSpring Health Services
BrightSpring Health Services Trading Up 16.6 %
NASDAQ BTSG traded up $2.97 on Friday, hitting $20.87. 4,015,296 shares of the company were exchanged, compared to its average volume of 1,303,327. The company's 50 day moving average price is $17.62 and its 200-day moving average price is $18.52. BrightSpring Health Services, Inc. has a twelve month low of $10.15 and a twelve month high of $24.82. The company has a debt-to-equity ratio of 1.63, a current ratio of 1.35 and a quick ratio of 0.97. The firm has a market capitalization of $3.65 billion, a P/E ratio of -80.27 and a beta of 2.02.
BrightSpring Health Services (NASDAQ:BTSG - Get Free Report) last posted its quarterly earnings results on Friday, May 2nd. The company reported $0.19 earnings per share for the quarter, topping analysts' consensus estimates of $0.09 by $0.10. The business had revenue of $2.88 billion for the quarter, compared to the consensus estimate of $2.74 billion. BrightSpring Health Services had a negative net margin of 0.38% and a positive return on equity of 4.16%. BrightSpring Health Services's revenue for the quarter was up 25.9% compared to the same quarter last year. During the same period in the prior year, the business posted $0.12 earnings per share. Analysts predict that BrightSpring Health Services, Inc. will post 0.59 earnings per share for the current fiscal year.
BrightSpring Health Services Company Profile
(
Free Report)
BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.
Read More

Before you consider BrightSpring Health Services, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and BrightSpring Health Services wasn't on the list.
While BrightSpring Health Services currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.